anti ifn alpha beta receptor alpha chain ifnar1 antibody (Bio X Cell)
98
Structured Review
Bio X Cell
anti ifn alpha beta receptor alpha chain ifnar1 antibody
Anti Ifn Alpha Beta Receptor Alpha Chain Ifnar1 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 98/100, based on 818 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ifn+alpha+beta+receptor+alpha+chain+ifnar1+antibody/Anti-Dopamine+Receptor+D3+Rabbit+Monoclonal+Antibody/pm40158445-62-4-50
Average 98 stars, based on 818 article reviews
Anti Ifn Alpha Beta Receptor Alpha Chain Ifnar1 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 98/100, based on 818 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ifn+alpha+beta+receptor+alpha+chain+ifnar1+antibody/Anti-Dopamine+Receptor+D3+Rabbit+Monoclonal+Antibody/pm40158445-62-4-50
Average 98 stars, based on 818 article reviews
anti ifn alpha beta receptor alpha chain ifnar1 antibody - by Bioz Stars,
2026-10
98/100 stars
Images
Related Articles
other:Article Title: Selective vascular disrupting therapy by lipid nanoparticle-mediated Fas ligand silencing and stimulation of STING. Article Snippet: Although recent therapeutic developments have greatly improved the outcomes of patients with cancer, it remains on ongoing problem, particularly in relation to acquired drug resistance.. Vascular disrupting agents (VDAs) directly damage tumor blood vessels, thus promoting drug efficacy and reducing the development of drug resistance; however, their low molecular weight and resulting lack of selectivity for tumor endothelial cells (TECs) lead to side effects that can hinder their practical use.. Here, we report a novel tumor vascular disrupting therapy using nucleic acid-loaded lipid nanoparticles (LNPs). |